Department of Food Microbiology, Hygiene and Safety, Institute of Food Science and Technology, Hungarian University of Agriculture and Life Sciences, H-1118, Somlói út 14-16, Budapest, Hungary.
Department of Food Process Engineering, Institute of Food Science and Technology, Hungarian University of Agriculture and Life Sciences, Budapest, Hungary.
World J Microbiol Biotechnol. 2022 Apr 20;38(6):95. doi: 10.1007/s11274-022-03279-4.
Galacto-oligosaccharides (GOS) are used as prebiotic ingredients in various food and pharmaceutical formulations. Currently, production of GOS involves the enzymatic conversion of lactose by transgalactosylation using β-galactosidase. The purity of the resulting product is low, typically limited to up to 55% GOS on total carbohydrate basis due to the presence of non-reacted lactose, and the formation of by-products glucose and galactose. In industrial practice high-purity GOS is manufactured by removing the unwanted mono- and disaccharides from raw GOS with simulated moving bed (SMB) chromatography. This purification step is associated with high processing cost that increases the price of pure GOS and limits its marketability. The last decades have witnessed a growing interest in developing competitive biotechnological processes that could replace chromatography. This paper presents a comprehensive review on the recent advancements of microbial GOS purification, a process commonly referred to as selective fermentation or selective metabolism. Purification strategies include: (i) removal of glucose alone or together with galactose by lactose negative yeast species, that typically results in purity values below 60% due to remaining lactose; (ii) removal of both mono- and disaccharides by combining the fast monosaccharide metabolizing capacity of some yeast species with efficient lactose consumption by certain lactose positive microbes, reaching GOS purity in the range of 60-95%; and (iii) the application of selected strains of Kluyveromyces species with high lactose metabolizing activity to achieve high-purity GOS that is practically free from lactose and monosaccharides.
半乳糖寡糖(GOS)被用作各种食品和药物制剂中的益生元成分。目前,GOS 的生产涉及使用β-半乳糖苷酶通过转半乳糖基化作用将乳糖转化为 GOS。由于存在未反应的乳糖以及葡萄糖和半乳糖的形成,所得产物的纯度较低,通常限于总碳水化合物基础上的高达 55%的 GOS。在工业实践中,通过模拟移动床(SMB)色谱从原始 GOS 中去除不需要的单糖和二糖来生产高纯度 GOS。这种纯化步骤与高加工成本相关,增加了纯 GOS 的价格并限制了其市场潜力。过去几十年,人们对开发可替代色谱的竞争性生物技术过程产生了浓厚的兴趣。本文全面回顾了微生物 GOS 纯化的最新进展,该过程通常称为选择性发酵或选择性代谢。纯化策略包括:(i)通过乳糖阴性酵母物种去除葡萄糖或与葡萄糖一起去除,由于残留的乳糖,通常导致纯度值低于 60%;(ii)通过某些酵母物种的快速单糖代谢能力与某些乳糖阳性微生物的有效乳糖消耗相结合,去除单糖和二糖,达到 60-95%的 GOS 纯度;(iii)应用具有高乳糖代谢活性的特定克鲁维酵母属菌株实现高纯度 GOS,实际上不含乳糖和单糖。